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Alterations in histamine responses 
between juvenile and adult urinary 
bladder urothelium, lamina propria 
and detrusor tissues
Zane Stromberga, Russ chess-Williams & christian Moro*
Inflammatory mediators may have a role in various lower urinary tract disorders. Histamine is known 
to induce significant increases in both the tension and frequency of spontaneous phasic contractions 
in both urothelium with lamina propria (U&LP) and detrusor muscle via the activation of H1 receptor 
in juvenile animal models. However, it is unclear whether age affects these contractile responses to 
histamine. This study assessed the histamine receptor subtypes mediating contraction in juvenile 
and adult porcine bladders and compared the urothelium with lamina propria and detrusor responses 
to histamine. Isolated tissue bath studies were conducted using strips of porcine U&LP and detrusor 
obtained from juvenile (6 months) and adult (3 years) animals exposed to histamine receptor agonists 
and antagonists. Treatment with histamine (100 µM) in U&LP of juvenile animals caused increases in 
baseline tension by 47.84 ± 6.52 mN/g (p < 0.001, n = 51) and by 50.76 ± 4.10 mN/g (p < 0.001, n = 
55) in adult animals. Furthermore, the frequency of spontaneous phasic contractions was significantly 
enhanced in response to histamine in U&LP of both juvenile and adult tissues (p < 0.001 for both age 
groups). Treatment with an H2 agonist in U&LP of juvenile animals decreased baseline tension by 13.97 
± 3.45 mN/g (n = 12, p < 0.05), but had no effect in adult animals. Inhibition of H1 receptors resulted 
in significantly reduced contractile responses of U&LP and detrusor to histamine in both juvenile and 
adult animals (p < 0.05). Treatment with an H2 receptor antagonist significantly enhanced contractions 
in juvenile preparations (n = 10, p < 0.05) but had no effect in adult preparations (n = 8). In detrusor, 
treatment with histamine (100 µM) in juvenile tissues showed a significantly higher increase in baseline 
tension of 19.10 ± 4.92 mN/g (n = 51) when compared to adult tissues exhibiting increases of 8.21 ± 
0.89 mN/g (n = 56, p < 0.05). The increases in the baseline tension were significantly inhibited by the 
presence of H1 receptor antagonists in both juvenile and adult detrusor preparations. Treatment with 
either the H2 receptor antagonist or agonist in detrusor had no effect on both juvenile and adult tissues. 
Therefore, the histamine receptor system may play an essential role in the maintenance of bladder 
function or in bladder dysfunction observed in some lower urinary tract disorders.
Normal bladder function deteriorates throughout adult life, age appearing to have a direct effect on bladder sensa-
tion, contractility and the ability to postpone voiding1. Ageing is associated with several changes that occur in the 
urinary bladder, such as a reduction in bladder capacity2 and an increase in bladder sensitisation3. It is also linked 
with marked increases in the prevalence of lower urinary tract symptoms, such as urinary frequency, voiding 
difficulties, decreased bladder contractions (as seen in underactive bladder) or uninhibited bladder contractions 
(as seen in overactive bladder)1. Urinary frequency and incontinence are common in the general population, with 
a significant increase over the age of 65 years4. With an increasing ageing population worldwide5, the incidence 
of lower urinary tract symptoms is likely to rise. The mechanisms underlying age-related bladder dysfunction 
are largely unclear, however, it is known that the prevalence of these symptoms generally increases with age6. At 
this current moment, there are a limited number of studies exploring the physiology of the lower urinary tract 
throughout ageing.
Centre for Urology Research, Faculty of Health Sciences and Medicine, Bond University, Queensland, 4229, Australia. 
*email: cmoro@bond.edu.au
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Age-related changes in the bladder structure, voiding patterns and neurotransmitter release have been stud-
ied to some extent, but they often provide conflicting evidence. Specifically, contractile responses to endogenous 
chemicals, noradrenaline, ATP and 5-HT, were increased with age7. Relaxatory responses to an adrenoceptor 
agonist, isoproterenol, were significantly inhibited in comparison to younger age groups, although the authors 
found no significant age-related differences in the contractile responses to acetylcholine, prostaglandin F2α, 
angiotensin II, vasoactive intestinal polypeptide or KCl. Additional functional studies involving human tissue 
also revealed that there is a non-neuronal release of acetylcholine from both the human U&LP and detrusor, 
which increases during ageing8 capable of impacting the overall contractility of the bladder. Furthermore, in 
a mouse model Daly, et al.9 found that ageing was associated with increases in voiding frequency, the release 
of ATP, frequency of spontaneous detrusor contractions, contractile responses of detrusor to muscarinic and 
purinergic agonists and afferent nerve activity while urothelial acetylcholine release was reduced. However, 
the mechanisms underlying these observed functional changes with ageing are unknown, with some variation 
exhibited between ex-vivo9 and in-vivo animal and human models10. Based on these contractile changes in 
response to different endogenous chemicals and pharmaceutical agents, it is likely that other receptor systems 
that are capable of inducing contractile changes in the bladder may also be affected by age and therefore an 
important avenue to explore further.
One such system is the histaminic receptor system that is involved in the modulation of the urinary bladder 
contractions and spontaneous activity;11 however it remains unclear how ageing impacts this receptor system. 
Histamine exerts its function by binding to four different G protein-coupled receptors: H1, H2, H3 and H412. 
Both H1 and H2 receptors are co-expressed in most tissues, including smooth muscle, epithelial tissue, neu-
rons and on various white blood cells13. When histamine binds to H1 receptor, it couples Gq/11 which stimulates 
phospholipase C (PLC) thereby initiating the generation of second messengers: inositol 1,4,5-triphosphate (IP3) 
and diacylglycerol (DAG)14. IP3 then leads to the release of calcium from the sarcoplasmic reticulum within 
the cell thereby initiating the process of smooth muscle contraction. The maintenance of these contractions is 
dependent on both internal and external sources of calcium. Activation of the H2 receptor couples Gs protein 
triggering adenylyl cyclase (AC) activation and accumulation of cAMP15 leading to calcium decrease in the cell16 
and relaxation of the smooth muscle. Both H3 and H4 receptors couple to Gi/o that inhibit AC thereby decreasing 
the cAMP levels. H4 receptors are also involved in mediating calcium mobilisation in mast cells and the release of 
calcium from the intracellular calcium stores17 which has been suggested as the mechanism responsible for mast 
cell accumulation in inflamed tissue.
Immunohistochemical analysis of cultured human detrusor cells identified the presence of all four hista-
mine receptor subtypes: H1, H2, H3 and H418. However, no immunohistochemical studies have been performed 
to determine the presence of these receptor subtypes in urothelium or lamina propria of the urinary bladder. 
Administration of histamine has previously shown a contractile response via the activation of the H1 recep-
tors in isolated guinea pig19–21 and rabbit22 bladders. Furthermore, our previous findings11 established functional 
responses to histamine not only in detrusor but also in urothelium with lamina propria layer of the urinary blad-
der via stimulation of H1 and H2 receptors.
There are currently no studies that have investigated the impacts of ageing on the contractile responses to 
histamine in the urinary bladder. In the mouse brain, age is associated with significant changes in the histamine 
receptor mRNA levels and subsequent reduction in the expression of the H1, H2 and H3 receptors23. In the 
human brain, similar observations were noted, where the H1 receptor subtype showed significant decreases with 
age24. The ability of histamine to induce vasodilation via the activation of H1 and H2 receptors is also altered with 
age25. The authors demonstrated that ageing has a direct effect on the signal transduction pathway activated via 
the H2 receptor while maintaining the function of H1 receptor. Furthermore, functional studies have shown  that 
decreases in the histamine-stimulated AC activity occur in aged rabbits, appearing to be represented as reduc-
tions to maximal responses rather than an alteration in receptor affinity26 and K+-induced histamine release is 
lowered in in vitro experiments involving aged rat hypothalamus27.
As a potent inflammatory mediator released from mast cells, histamine may play a key role in the pathogenesis 
of various lower urinary tract disorders. Several research studies have reported signs of inflammation in urinary 
bladder biopsies obtained from patients suffering from bladder overactivity28,29 and established a central role of 
inflammation in the pathogenesis of IC/BPS30. An increased expression of monocyte chemoattractant protein-1 
(MCP-1), which stimulates the release of inflammatory mediators from mast cells31,32, has been suggested as a 
contributor to the inflammation observed in the tissue33. Specifically, in the urinary bladder, mast cells can be 
found in all layers of the bladder wall, including urothelium, lamina propria and detrusor smooth muscle34,35. 
When urothelial cells of the bladder are damaged or stressed, they are capable of releasing ATP36, IL-3337 and β 
-defensins that directly trigger the degranulation of mast cells and subsequent release of pro-inflammatory medi-
ators, such as histamine, prostaglandins, proteases and cytokines38.
Increased cellular responsiveness to histamine is a key feature of many inflammatory conditions39. However, 
it is unknown whether the histamine receptor system directly mediates contractions of the bladder dome and is 
associated with bladder pathologies. Histamine is known to induce significant increases in both the tension and 
frequency of spontaneous phasic contractions in both the urothelium with lamina propria and in the underlying 
detrusor muscle via the activation of the H1 receptors11. It also enhances the mechanosensitivity of nearby affer-
ent nerves to bladder distension, resulting in an increased neuronal activation in the spinal cord40. In addition, 
this effect may work in conjunction with other inflammatory-cell released chemicals such as 5-HT41 to induce or 
maintain various lower urinary tract disorders. However, it is unclear how age affects the contractile responses 
to histamine.
Based on prior histamine receptor expression research, it is hypothesised that responses from stimulating the 
H1 receptor will be reduced with ageing in both U&LP and detrusor smooth muscle. It is also hypothesised that 
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stimulation of the H2 receptor, shown to be involved in inhibitory responses in urothelium with lamina propria11, 
will have a more significant impact on juvenile tissues when compared to adult tissues. The aim of this study was 
to compare responses to histamine in both U&LP and detrusor tissues from porcine juvenile and adult bladders.
Materials and Methods
Tissue source and acquisition. Urinary bladders of crossbred Large-White-Landrace-Duroc (Suf scrofa 
domestica) pigs were used as the tissue in this study. Juvenile samples were obtained from prepubescent pigs aged 
6 months old at 80 kg live-weight. Adult tissues were taken from sow animals, aged 2–3 years old at ~200 kg live-
weight. All bladders were obtained from the local abattoir after slaughter for the routine commercial provision of 
food with no animals bred, harmed, culled, interfered, or interacted with as part of this research project. As such, 
animal ethics approval was not required (Queensland Government, 2016).
Immediately after the slaughter of pigs at the abattoir, the bladders were removed and directly placed in a 
cold Krebs-bicarbonate solution at 4 °C (NaCl 118.4 mM, NaHCO3 24.9 mM, CaCl2 1.9 mM, MgSO4 2.41 mM, 
KCl 4.6 mM, KH2PO4 1.18 mM and D-glucose 11.7 mM). After collection, the container with porcine bladders 
was stored in a portable cooler and transported back to Bond University’s research laboratory to be set up within 
3 hours of the animal’s slaughter. Upon return, tissues were prepared for experiments by removing the ureters and 
urethra, serosa and arteries on the outside of the bladder.
Tissue preparation. Intact strips of the urinary bladder were horizontally removed from the anterior base 
wall of the bladder dome region. Urothelium with lamina propria was dissected from the underlying detrusor 
layer, consistent with methods carried out in past studies11,42. Throughout the preparation and dissection stage, 
tissue strips were constantly washed with a cold Krebs-bicarbonate solution.
Once the tissues were dissected, adjacent strips of U&LP and detrusor (each strip is 10 mm in length and 
5 mm in width) were mounted vertically between an isometric force transducer (MCT050/D, ADInstruments, 
Castle Hill, Australia) and a fixed hook in a 10 mL organ bath (Labglass, Brisbane, Australia), and superfused with 
Krebs-bicarbonate solution (NaCl 118.4 mM, NaHCO3 24.9 mM, CaCl2 1.9 mM, MgSO4 2.41 mM, KCl 4.6 mM, 
KH2PO4 1.18 mM and D-glucose 11.7 mM) at 37 °C and carbogen (95% oxygen and 5% carbon dioxide).
After mounting of tissues, strips of U&LP and detrusor were washed three times with warm 
Krebs-bicarbonate solution and the tension manually adjusted to 2 g on a moveable transducer positioner with 
a fine adjustment lever. As such, baseline tension for each experiment was calculated from this 2 g set-point. 
Tissues were then left to equilibrate for 30 min in the absence (control) and presence (experimental) of a specific 
histamine receptor antagonist. After the equilibration period, a single dose of histamine was added to both 
control and experimental tissues. The increases in baseline tension and in the frequency and amplitude of spon-
taneous phasic contractions were recorded simultaneously through an isometric force transducer on a Powerlab 
system using LabChart v7 software (MCT050/D, ADInstruments, Castle Hill, Australia). The viability of the 
tissue was ensured by adding a single dose of carbamoylcholine chloride (10 µM, Sigma Aldrich, Missouri, 
USA) to all tissues at the very end of each experiment. U&LP or detrusor strips that did not respond to carba-
moylcholine chloride were deemed as non-viable and were not included in the analysis. At the conclusion of 
each experiment, tissues were removed from each organ bath and measured on a weighing scale to an accuracy 
of 1 mg (0.001 g).
Measurements and data collection. Measurements of the baseline tension and the frequency and ampli-
tude of spontaneous phasic contractions were taken before the agonist was added and during peak contractile 
response after the addition of the agonist. The frequency of spontaneous contractions was measured from the 
total number of phasic waves occurring over 2–3 minutes, calculated as an average, and expressed as contractions 
per minute (cpm). The amplitude of each contraction was measured as the tension differences between the aver-
aged lowest and highest point of each phasic wave. Baseline tension was measured from the lowest point of each 
spontaneous phasic contraction before treatment with an agonist and during peak contractile response. Changes 
in both baseline tensions and the amplitudes of spontaneous phasic contractions were expressed as Newton force 
per gram tissue weight (mN/g).
Pharmaceutical agents. Histamine dihydrochloride, amthamine dihydrobromide, pyrilamine maleate salt, 
cimetidine, thioperamide maleate salt, indomethacin, atropine, and Nω-Nitro-L-arginine were obtained from 
Sigma-Aldrich (Missouri, USA), and fexofenadine hydrochloride, αβ-methylene ATP (sodium salt) and cypro-
heptadine hydrochloride hydrate from Cayman Chemicals (Michigan, USA). Concentrations chosen for the ago-
nists and antagonists were selected based on their selectivity at each receptor and consistent with concentrations 
used in previous studies11.
Statistical analysis. Data were graphed and analysed using GraphPad Prism version 8.3 for Windows 
(GraphPad Software, La Jolla California USA) and results expressed as the mean change ± SEM. Within experi-
ments using only juvenile, or only adult tissues, data were calculated as the total change between the control and 
its paired experimental sample. For comparisons between age groups, data comparing juvenile with adult samples 
were calculated from the averaged changes between each tissue’s responses when placed under identical exper-
imental parameters. All responses were compared using a Student’s two-tailed t-test, with p < 0.05 considered 
as statistically significant. A paired Student’s two-tailed t-test was applied to tissues with direct controls (within 
each juvenile or adult experiment) and an unpaired Student’s two-tailed t-test was applied to make comparisons 
between juvenile and adult groups.
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Results
Histamine agonists for stimulating spontaneous U&LP activity in juvenile and adult tissues. 
In the absence of any stimulation, strips of U&LP naturally developed spontaneous phasic contractions. In juve-
nile animals, spontaneous contractions occurred at 3.37 ± 0.05 cycles per minute (cpm, n = 159) with an ampli-
tude of 32.63 ± 1.81 mN/g (n = 159). In adult animals, these contractions occurred at 3.37 ± 0.11 cpm (n = 59) 
with an amplitude of 34.88 ± 3.79 mN/g (n = 59). There was no significant difference in the frequency or ampli-
tude of spontaneous phasic contractions between juvenile (n = 159) and adult (n = 59) tissues.
When histamine (100 µM) was added to U&LP strips of juvenile animals, the frequency of spontaneous phasic 
contractions increased by 1.29 ± 0.26 cpm (p < 0.001, n = 51) and the amplitude of each contraction decreased 
by 5.54 ± 1.60 mN/g (p < 0.001, n = 51). In U&LP strips of adult animals, an increase to the frequency of sponta-
neous phasic contractions occurred at 1.18 ± 0.16 cpm (p < 0.001, n = 55) and decrease in the amplitude of these 
contractions by 10.05 ± 2.06 mN/g (p < 0.001, n = 55). The increases in the baseline tension and in the frequency 
and amplitude of spontaneous phasic contractions in response to histamine (100 µM) were not significantly dif-
ferent between juvenile (n = 51) and adult (n = 55) tissues.
Treatment with H2 receptor agonist amthamine had no effect on the frequency or on the amplitude of the 
spontaneous phasic contractions in either juvenile or adult U&LP preparations.
Histamine agonists for stimulating spontaneous detrusor activity in juvenile and adult tissues. 
In detrusor preparations of juvenile animals, spontaneous activity in the absence of any stimulation was present in 
13% of preparations with an average frequency of 2.06 ± 0.30 cpm and amplitude of 18.29 ± 3.07 mN/g (n = 7). 
After the addition of histamine (100 µM), the frequency was significantly enhanced, increasing to 4.47 ± 0.69 cpm 
(n = 7, p < 0.01) with an amplitude of 29.07 ± 6.40 mN/g (n = 7, NSD). In adult preparations, this activity 
was present in 30% of all preparations (n = 17) with an average frequency of 1.95 ± 0.15 cpm and amplitude of 
14.26 ± 2.15 mN/g. In response to histamine (100 µM), frequency of spontaneous contractions was significantly 
enhanced to 2.39 ± 0.16 cpm (n = 17, p < 0.01) with an amplitude of 24.22 ± 4.36 mN/g (n =17, p < 0.05). 
There were no significant differences in the frequency or amplitude of spontaneous phasic contractions exhibited 
by detrusor preparations of both juvenile and adult animals before the treatment with histamine. During peak 
response to histamine (100 µM), strips of detrusor from juvenile animals (n = 7) exhibited a significantly higher 
frequency of spontaneous contractions when compared to adult tissues (n = 17, p < 0.001). The amplitude of 
spontaneous contractions exhibited during peak response to histamine (100 µM) was not significantly different 
between the two age groups. Spontaneous phasic activity was not present at any point during the experiment in 
35% of juvenile preparations and in 34% (n = 18) of adult preparations (n = 19).
In those detrusor strips that did not develop spontaneous activity before the addition of the agonist, treatment 
with histamine (100 µM) initiated contractions in 59% (n = 26) of preparations of juvenile animals with a fre-
quency of 2.90 ± 0.20 cpm and amplitude of 24.46 ± 8.40 mN/g. In adult animals, contractions were initiated in 
51% of preparations (n = 20) with an average frequency of 2.83 ± 0.32 cpm and amplitude of 14.79 ± 1.61 mN/g. 
There were no significant differences in the frequency and amplitude of spontaneous contraction developed after 
treatment with histamine (100 µM) between the two age groups.
Histamine agonists for stimulating contractions in U&LP and detrusor in juvenile and adult tissues. 
When histamine (100 µM) was added to U&LP strips of juvenile animals, baseline tension increased by 47.84 ± 
6.52 mN/g (p < 0.001, n = 51, Fig. 1). Similarly, the addition of histamine (100 µM) to U&LP strips of adult ani-
mals increased the baseline tension by 50.76 ± 4.10 mN/g (p < 0.001, n = 55, Fig. 1). In detrusor preparations, 
juvenile tissues showed significantly greater (p < 0.05) increases in baseline tension of 19.10 ± 4.92 mN/g (n = 
51) when compared to tissues from adult animals which exhibited increases of 8.21 ± 0.89 mN/g (n = 56, Fig. 1) 
in response to histamine (100 µM).
In bladders of juvenile animals, U&LP responses to the H2 agonist amthamine (1 µM) resulted in a baseline 
tension decrease of 13.97 ± 3.45 mN/g (n = 12, p < 0.05). The preparation of juvenile U&LP tissues showed a 
significantly greater reduction in the baseline tension in response to amthamine (1 µM) when compared to adult 
U&LP tissues (p < 0.05, Fig. 2). In detrusor preparations, the addition of amthamine (100 µM) in both juvenile (n 
= 4) and adult (n = 8) tissues had no effect on the baseline tension (Fig. 2).
Receptor-selective antagonists in U&LP preparations of juvenile and adult tissues. The influ-
ence of three different H1 antagonists and their baseline tension responses to histamine was compared between 
juvenile and adult tissues. Strips of U&LP treated with the H1 receptor antagonists pyrilamine (30 nM), fexofen-
adine (1 μM) and cyproheptadine (30 nM) showed significant inhibition of the increases in the baseline tension 
in responses to histamine in both juvenile and adult preparations (100 μM, p < 0.01 for all, Table 1). None of the 
baseline tension responses to histamine (100 μM) in the presence of any of the three H1 antagonists were signifi-
cantly different between juvenile or adult tissues (unpaired Student’s t-test, p = NSD for all).
Treatment with cimetidine (1 μM, H2 antagonist) in juvenile U&LP tissues significantly enhanced increases in 
the baseline tension by 19.05 ± 8.32 mN/g (n = 10, p < 0.05) in response to histamine (100 μM) but had no effect 
in adult tissues (n = 8). Treatment with thioperamide (1 μM, H3/H4 antagonist) in juvenile tissues caused signifi-
cantly enhanced increases in the baseline tension of 27.33 ± 8.67 mN/g (n = 6, p < 0.05) in response to histamine 
(100 μM). The opposite effect was observed in adult tissues in response to histamine (100 μM), where increases 
in the baseline tension were significantly inhibited by 17.64 ± 7.22 mN/g (n = 8, p < 0.05, Table 1). However, 
upon further investigation involving a combination of histamine receptor antagonists, it was revealed that thi-
operamide had no effect baseline tension in response to histamine (100 μM) in both juvenile and adult tissues.
In both juvenile and adult preparations, increases in the frequency of spontaneous phasic contractions were 
significantly inhibited in response to histamine (100 μM) when the tissues were treated with pyrilamine (30 nM, 
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Figure 1. Influence of age on the increases in baseline tension in response to histamine (100 µM) in U&LP (left) 
and detrusor (right) preparations. *p < 0.05.
Figure 2. Influence of age in response to H2 agonist amthamine (1 µM) in U&LP (left) and detrusor (right) 
preparations. *p < 0.05.
Antagonist
Juvenile (mN/g) Adult (mN/g)
Absence Presence n Absence Presence n
Pyrilamine 34.82 ± 11.09 6.39 ± 5.74*** 14 34.52 ± 4.14 17.56 ± 2.81** 14
Fexofenadine 44.63 ± 11.78 −1.63 ± 1.01** 8 46.03 ± 4.44 −0.59 ± 2.21** 8
Cyproheptadine 59.56 ± 18.97 21.00 ± 8.11* 8 66.18 ± 7.97 28.46 ± 6.04** 8
Cimetidine 61.70 ± 22.26 80.75 ± 28.12* 10 41.40 ± 4.45 50.81 ± 7.85 8
Thioperamide 59.92 ± 14.35 87.25 ± 14.71* 6 51.47 ± 9.78 33.82 ± 5.19* 8
Table 1. Comparison of U&LP changes to baseline tension (mN/g) in response to histamine (100 µM) in the 
absence and presence of histamine receptor antagonists (mean change ± SEM) in juvenile and adult urinary 
bladders. *p < 0.05, **p < 0.01, ***p < 0.001. Paired Student’s t-test.
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p < 0.05 for both). Treatment with fexofenadine (1 µM) caused complete inhibition to the increases to the base-
line tension in response to histamine (100 µM) in both juvenile (n = 8, p < 0.01) and adult tissues (n = 8, 
p < 0.01). In tissues from juvenile animals, cyproheptadine (30 nM) significantly inhibited increases in spontane-
ous activity (n = 8, p < 0.05) in response to histamine (100 µM), although this was not replicated in adult tissues 
(n = 8, Table 2).
Treatment with cimetidine (1 µM, H2 antagonist) had no effect on the frequency and amplitude of spontane-
ous phasic contractions in both juvenile tissues in response to histamine (100 μM). The addition of thioperamide 
(1 µM, H3/H4 antagonist) caused a significant inhibition in the frequency of spontaneous activity in tissues from 
adult animals (n = 8, p < 0.01), but had no effect in tissues obtained from juvenile animals (n = 6). None of the 
five histamine receptor antagonists had any influence on the amplitude of spontaneous phasic contractions in 
response to histamine (100 μM) in both juvenile and adult preparations (Table 2).
The potential contributions of other receptor systems present in the U&LP to histamine-induced (100 μM) 
contractile responses were investigated. Neither baseline tension, the frequency or amplitude of spontaneous pha-
sic contractions in response to histamine in both juvenile and adult strips of U&LP were affected by the presence 
of the muscarinic receptor antagonist atropine (1 µM), cyclooxygenase (COX) inhibitor indomethacin (5 µM), 
nitric oxide synthase inhibitor Nω-Nitro-L-arginine (L-NNA, 100 µM) or the P2X receptor desensitising agonist 
αβ-methylene ATP (αβm-ATP, 10 µM).
Receptor-selective antagonists in detrusor preparations of juvenile and adult tissues. The 
presence of pyrilamine in juvenile detrusor preparations showed significantly greater inhibition of the contractile 
response to histamine (100 μM) when compared to adult tissues (p < 0.05). In juvenile preparations, increases in 
baseline tension were inhibited by 12.46 ± 3.88 mN/g (n = 14, p < 0.05) whereas in adult these increases were 
inhibited by 3.91 ± 1.73 mN/g (n = 14, p < 0.05, Table 3). Treatment with an alternative H1 antagonist fexofen-
adine inhibited increases in baseline tension to histamine (100 μM) by 9.61 ± 3.95 mN/g (n = 8, p < 0.05) in 
juvenile preparations and by 4.17 ± 1.33 mN/g (n = 8, p < 0.05) in adult. Similarly, the addition of H1 antagonist 
cyproheptadine caused inhibition of the contractile responses to histamine (100 μM) by 5.57 ± 1.22 mN/g (n = 8, 
p < 0.01) in juvenile tissues and by 3.00 ± 1.22 mN/g (n = 8, p < 0.05, Table 3) in adult tissue preparations. None 
of the baseline tension responses to histamine (100 μM) in the presence of any of the three H1 antagonists were sig-
nificantly different between juvenile or adult detrusor tissues (unpaired Student’s two-tailed t-test, p = NSD for all).
Treatment with the H2 antagonist cimetidine in detrusor from juvenile animals (n = 8) demonstrated some 
inhibition of the contractile responses to histamine (100 μM), however, this response was not significant. In 
adult tissues (n = 8), cimetidine did not exert any effect on the increases in baseline tension in response to hista-
mine (100 μM). Similarly, the H3 and H4 receptor dual antagonist thioperamide had no effect on the contractile 
responses to histamine (100 μM) in both juvenile (n = 6) and adult (n = 8) detrusor preparations (Table 3).
Baseline tension in response to histamine (100 μM) in both juvenile and adult strips of detrusor were not 
affected by the presence of the muscarinic receptor antagonist atropine (1 µM), cyclooxygenase (COX) inhibitor 
indomethacin (5 µM), nitric oxide synthase inhibitor Nω-Nitro-L-arginine (L-NNA, 100 µM) or P2X receptor 
desensitising agonist αβ-methylene ATP (αβm-ATP, 10 µM).
Discussion
This study shows that ageing has varying effects on the contractile responses of U&LP or detrusor smooth mus-
cle of the porcine bladder. This research has provided several novel findings that further our understanding of 
histamine’s influence on the bladder contractility throughout ageing. There are five main findings of this study. 
(1) Age does not affect increases in the baseline tension or the frequency of spontaneous phasic contractions in 
response to histamine in U&LP. (2) Maximal contractile responses in detrusor smooth muscle of adult tissues 
were significantly smaller when compared to contractions observed in juvenile animals. (3) Inhibition of the H2 
receptors significantly enhanced increases to baseline tension in response to histamine in juvenile animals but 
had no effect in adult animals. (4) Stimulation of the H2 receptors causes relaxation of U&LP in juvenile but 
not in adult tissues. (5) Neither the muscarinic nor purinergic receptor systems are involved in the contractile 
response to histamine.
The current focus of pharmacological interventions for lower urinary tract symptoms has been primarily 
focused on muscarinic receptor antagonists due to the involvement of this receptor system in bladder voiding43. 
However, the use of antimuscarinics is associated with several side effects due to muscarinic receptor localisation 
throughout the body that limits their overall tolerability44. Due to the troublesome side effects, the long-term 
adherence and persistence to this treatment are generally low45–47 and declines rapidly after the initiation of the 
treatment48. Furthermore, the symptoms associated with uninhibited contractions that occur in patients with 
overactive bladder are considered to occur, in part, through stimulation of receptor pathways other than the mus-
carinic system6. The influence of different receptor systems within the U&LP has been of particular interest, spe-
cifically their impact on the spontaneous contractile activity that is known to occur during the filling phase49,50. 
These contractions may also play a role in the regulation of tone and the overall continence mechanisms, as 
previously hypothesised in the literature50.
Some of the chemicals that are capable of mediating contractions in the bladder include ATP51, 5-HT or ser-
otonin41, prostaglandins52 and histamine11. Specifically, histamine exerts its function in both U&LP and detrusor 
smooth muscle via the activation of the H1 receptor as confirmed in guinea pig19–21, rabbit22 and pig11 animal 
models. The stimulation of the H2 receptor in porcine U&LP has recently been associated with inhibited con-
tractions to histamine;11 however this finding was not present in the detrusor tissue. Having established a clear 
involvement of the histamine receptor system in mediating bladder contractions and spontaneous activity in 
tissues obtained from juvenile animals11, we undertook this study to determine how ageing impacts the responses 
to histamine and the involvement of the different histamine receptor subtypes. Our present study also confirmed 
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the lack of involvement of purinergic or cholinergic receptor systems in the mediation of histamine-induced 
contractile responses that was first noted in Stromberga, et al.11 study.
This study found that maximal responses to histamine in detrusor were significantly lower in adult prepara-
tions when compared to juvenile preparations. Interestingly, a general decline in the contractile responses evoked 
by high potassium and muscarinic receptor agonist in adult rats has previously been reported in detrusor smooth 
muscle53,54. The mechanisms underlying this are unclear, but the urinary bladder contains elastic and collagen 
fibres that are responsible for the distensibility of the bladder wall and thus play a role in the generation of con-
tractions and intravesical pressure55. As there is greater deposition of collagen observed in ageing bladder56,57, it is 
possible that the decrease in peak contractions occurred due to reduced compliance in adult detrusor.
Maximal contractile responses in U&LP and the frequency of spontaneous phasic contractions remained the 
same in both juvenile and adult tissues, indicating that the contractile properties of this layer were not affected by 
age. However, it appears that only the H1 receptor is functional in adult preparations of U&LP. In juvenile tissues, 
the H2 receptor has been shown to inhibit contractile responses to histamine11, yet neither stimulation nor inhi-
bition of this receptor had any effect in adult tissues. This lack of response might have occurred due to a general 
reduction in the responsiveness of the H2 receptors within the U&LP layer, although this is yet to be confirmed. 
Based on our previous investigation on the histamine receptor system11, H3 and H4 receptor antagonist thiop-
eramide exerts its function on other histamine receptor subtypes. As both H3 and H4 receptors have no direct 
contractile involvement in smooth muscle contractions15, it appears that this receptor agonist has a secondary 
effect on stimulating the H2 receptor in juvenile samples, thereby producing enhanced contractile responses. The 
involvement of this antagonist in enhancing contractions was ruled out using combination antagonist studies, 
where both H1 and H2 receptors were inhibited. It was determined that that thioperamide had no influence con-
tractility of the U&LP or detrusor11. In adult samples, no responses were observed to the stimulation or inhibition 
of the H2 receptor. Thereby, it is likely that the inhibition of contractile responses in the presence of thioperamide 
observed in adult samples was a result of stimulating the H1 receptors.
Overall, the identification of a functional response to histamine agonists presents an interesting direction for 
future studies in the histaminic receptor signalling. The identification of which second-messenger systems are 
coupled to this response could provide more insight into the mechanisms underlying the contraction. In addi-
tion, future studies utilising immunocytochemical, immunohistochemical or radioligand binding assessments 
to determine the location, density, and prevalence of the histamine receptors would provide additional insights 
into this response.
Conclusions
The histamine receptor system may play an important role in the maintenance of bladder function or in the 
stimulation of some contractile disease states in both juvenile and adult tissues. This study presents the possibility 
that a contributing factor to increased prevalence of bladder contractile disorders in an ageing population may be 
due to a general reduction in the responsiveness of histamine receptors or the lack of response to H2 stimulation.
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Antagonist
Juvenile (cycles per minute) Adult (cycles per minute)
Absence Presence n Absence Presence n
Pyrilamine 1.27 ± 0.29 0.23 ± 0.22** 12 0.89 ± 0.24 0.34 ± 0.10* 14
Fexofenadine 1.11 ± 0.28 −0.09 ± 0.14** 8 0.81 ± 0.15 −0.13 ± 0.09** 8
Cyproheptadine 1.87 ± 0.78 0.56 ± 0.28* 8 1.01 ± 0.29 0.77 ± 0.28 8
Cimetidine 1.77 ± 0.57 1.32 ± 0.75 10 1.40 ± 0.77 1.18 ± 0.26 8
Thioperamide 1.49 ± 0.63 1.76 ± 0.55 6 1.84 ± 0.41 0.63 ± 0.27** 8
Table 2. Comparison of U&LP changes in the frequency of spontaneous phasic contractions (cpm) to 
histamine (100 µM) in the absence and presence of histamine receptor antagonists (mean change ± SEM) in 
juvenile and adult urinary bladders. *p < 0.05, **p < 0.01, ***p < 0.001. Paired Student’s two-tailed t-test.
Antagonist
Juvenile (mN/g) Adult (mN/g)
Absence Presence n Absence Presence n
Pyrilamine 17.11 ± 4.93 4.65 ± 1.90* 8 11.20 ± 2.00 5.72 ± 1.15** 13
Fexofenadine 10.88 ± 3.65 1.27 ± 0.50* 8 4.53 ± 1.39 0.06 ± 0.13* 8
Cyproheptadine 7.06 ± 0.86 1.49 ± 0.66** 8 4.81 ± 1.38 1.52 ± 0.42* 8
Cimetidine 12.12 ± 3.28 5.48 ± 1.55 10 6.62 ± 2.02 8.30 ± 2.73 8
Thioperamide 18.88 ± 6.09 13.25 ± 3.33* 4 8.04 ± 2.02 5.64 ± 1.24 8
Table 3. Comparison of detrusor changes to baseline tension (mN/g) in response to histamine (100 µM) in the 
absence and presence of histamine receptor antagonists (mean change ± SEM) in juvenile and adult urinary 
bladders. *p < 0.05, **p < 0.01, ***p < 0.001. Paired Student’s two-tailed t-test.
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